10 things I hate about proteomics
Abstract
Despite the title, says Dr. Williams, “this presentation is about my romance with proteomics.” From myths about assay size (and why it’s annoying when people say, “3,000 proteins is enough”) to the issue surrounding cis pQTLs (and why they’re “a nice party trick, but mostly biologically boring”), Dr. Williams explains in a fun – but serious – way how proteomics is revolutionizing drug discovery research and precision medicine worldwide today. He also couldn’t resist telling the story about what happens when two proteins walk into a bar. (Spoiler alert: This is why he has a career in medicine and not in stand-up comedy.)
Stephen A. Williams, MD, PhD
Chief Medical Officer
SomaLogic, Inc.
Stephen Williams, MD, PhD, is Chief Medical Officer at SomaLogic and is responsible for Clinical R&D, Medical Affairs, and Regulatory and Quality. He oversees clinical application of the SomaScan® Platform and has also had roles in launching the life sciences commercial business, assay development and bioinformatics.
Read more about Dr. Williams here.
10 things I hate about proteomics
A presentation by Stephen Williams, MD, PhD
More webinars
WebinarSerum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups
Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched healthy controls.
WebinarData Summit 2025
Take your research further with expert insights from the SomaScan™ Data Summit. Explore the latest platform updates, advanced data analysis tools, and innovative applications for SOMAmer™ reagents. From optimizing sample quality to customizing panels beyond 7K and 11K, this event is packed with knowledge to help you get the most from your data.
WebinarBoutique Webinar: Multiomic Breakthroughs: Immune Monitoring for Precision Disease Detection
Helen McGuire, PhD, talks about how her team introduced a cutting-edge approach to immune monitoring that simplifies sample collection in multi-site clinical trials, particularly benefiting remote and underrepresented populations.